Inflarx N V's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Inflarx N V's ROI in the fourth quarter of 2025?
Inflarx N V recorded a cumulative net loss of $-67 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -140.95%.

Within the Healthcare sector 707 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 4255.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) II. Quarter
Y / Y Investment Change TTM	-49.99 %	-52.61 %	-46.43 %	-29.03 %	-10.41 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	50	47	47	47	64
Return On Investment (TTM)	-140.95 %	-60.71 %	-127.85 %	-79.77 %	-74.84 %
IFRX's Overall Ranking	# 4255	#	#	#	#
Seq. Investment Change TTM	-7.04 %	-16.73 %	-21.33 %	-17.88 %	-11.91 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-67	-31	-79	-63	-72

IFRX Company Profile >> Back to IFRX Roi Comparisons >> See Annual IFRX Return On Investment

Return On Investment IFRX's Ranking
Within:	No.
Industry	# 322
Sector	# 708
Overall	# 4255

Return On Investment Statistics
High	Average	Low
-32.99 %	-60.77 %	-108.05 %
(Dec 31 2022)

Financial Statements
Inflarx N V's IV. Quarter Investments	$ 50 Millions	IFRX's Balance sheet
Inflarx N V's IV. Quarter Income	$ -51 Millions	Quarterly IFRX's Income Statement
IFRX's Income by Division		See IFRX's Income by Division

IFRX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2020) 2020
Total Investments in Millions	50	64	114	96	96
Y / Y Investment Growth	-22.64 %	-44.01 %	19.54 %	0.13 %	-20.85 %
Net Income in Millions	-52	-50	-46	-31	-39
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-104.17 %	-77.85 %	-40.36 %	-32.47 %	-40.59 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IFRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IFRX's Competitors
Subscribers only: Roi for Inflarx N V's Suppliers
Subscribers only: Return On Investment for IFRX's Customers

Other Ratios
IFRX's Roa	IFRX's Inventory Turnover Ratio	IFRX's Growth Rates	IFRX's Dividend Statistics
	IFRX's Profitability Ratios	IFRX's Asset Turnover Ratio	IFRX's Dividend Growth
IFRX's Roe	IFRX's Valuation Ratios	IFRX's Financial Strength Ratios	IFRX's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector

ROI

Date modified: 2026-07-07T11:32:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.